Authors:
Eron, JJ
Haubrich, R
Lang, W
Pagano, G
Millard, J
Wolfram, J
Snowden, W
Pedneault, L
Tisdale, M
Citation: Jj. Eron et al., A phase II trial of dual protease inhibitor therapy: Amprenavir in combination with indinavir, nelfinavir, or saquinavir, J ACQ IMM D, 26(5), 2001, pp. 458-461
Authors:
Scott, T
Garris, C
Rogers, M
Graham, N
Garrett, L
Pedneault, L
Citation: T. Scott et al., Safety profile and tolerability of amprenavir in patients enrolled in an early access program, CLIN THER, 23(2), 2001, pp. 252-259
Authors:
Faron, G
Drouin, R
Pedneault, L
Poulin, LD
Laframboise, R
Garrido-Russo, M
Fraser, WD
Citation: G. Faron et al., Recurrent cleft lip and palate in siblings of a patient with malabsorptionsyndrome, probably caused by hypovitaminosis A associated with folic acid and vitamin B-2 deficiencies, TERATOLOGY, 63(3), 2001, pp. 161-163
Authors:
Goodgame, JC
Pottage, JC
Jablonowski, H
Hardy, WD
Stein, A
Fischl, M
Morrow, P
Feinberg, J
Brothers, CH
Vafidis, I
Nacci, P
Yeo, J
Pedneault, L
Citation: Jc. Goodgame et al., Amprenavir in combination with lamivudine and zidovudine versus lamivudineand zidovudine alone in HIV-1-infected antiretroviral-naive adults, ANTIVIR TH, 5(3), 2000, pp. 215-225
Authors:
DeGruttola, V
Dix, L
D'Aquila, R
Holder, D
Phillips, A
Ait-Khaled, M
Baxter, J
Clevenbergh, P
Hammer, S
Harrigan, R
Katzenstein, D
Lanier, R
Miller, M
Para, M
Yerly, S
Zolopa, A
Murray, J
Patick, A
Miller, V
Castillo, S
Pedneault, L
Mellors, J
Citation: V. Degruttola et al., The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan, ANTIVIR TH, 5(1), 2000, pp. 41-48
Authors:
Pedneault, L
Brothers, C
Pagano, G
Tymkewycz, P
Yeo, J
Millard, J
Fetter, A
Citation: L. Pedneault et al., Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection, CLIN THER, 22(12), 2000, pp. 1378-1394